
Happiness Biotech Group Limited HAPP
Annual report 2022
added 08-16-2022
Happiness Biotech Group Limited DIO Ratio 2011-2026 | HAPP
Annual DIO Ratio Happiness Biotech Group Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.76 | 13.1 | 21.1 | 11.3 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.1 | 6.76 | 13.1 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Alnylam Pharmaceuticals
ALNY
|
43.5 | $ 327.37 | -1.81 % | $ 42.9 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
166 | $ 21.55 | -0.6 % | $ 1.01 B | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Akebia Therapeutics
AKBA
|
147 | $ 1.42 | -8.71 % | $ 365 M | ||
|
Aquestive Therapeutics
AQST
|
120 | $ 4.18 | -1.3 % | $ 447 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 24.21 | -1.53 % | $ 3.08 B | ||
|
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.58 | -1.27 % | $ 6.83 B | ||
|
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.52 | 1.68 % | $ 405 M | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Caladrius Biosciences
CLBS
|
35.8 | - | -16.75 % | $ 25.8 M | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M |